APA (7th ed.) Citation

Xu, C., Gao, X., Ren, T., Geng, H., Yang, K., Huang, Y., . . . Zhao, Q. (2024). The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk. Pharmacological Research, 203, N.PAG. https://doi.org/10.1016/j.phrs.2024.107142

Chicago Style (17th ed.) Citation

Xu, Chang, et al. "The ADAM17 Inhibitor ZLDI-8 Sensitized Hepatocellular Carcinoma Cells to Sorafenib Through Notch1-integrin β-talk." Pharmacological Research 203 (2024): N.PAG. https://doi.org/10.1016/j.phrs.2024.107142.

MLA (9th ed.) Citation

Xu, Chang, et al. "The ADAM17 Inhibitor ZLDI-8 Sensitized Hepatocellular Carcinoma Cells to Sorafenib Through Notch1-integrin β-talk." Pharmacological Research, vol. 203, 2024, p. N.PAG, https://doi.org/10.1016/j.phrs.2024.107142.